Qiagen N.V. (QGEN) Stock

Qiagen N.V. (QGEN) is a Healthcare stock trading at $36.96 (as of 2026-06-18), with a market capitalization of $7.94B and a trailing P/E of 18.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

QIAGEN provides sample-to-insight solutions that support molecular analysis of biological materials. Its offerings include consumables and instruments for preparing and purifying nucleic acids, processing workflows for genotyping and gene expression, and diagnostic assays for areas such as infectious disease testing, post-transplant monitoring, prenatal testing, and genomic variant analysis.

Valuation — source: SEC EDGAR (first-party)
Price$36.96
Market Cap$7.94B
P/E Ratio18.9
EV / EBITDA13.3
Price / Book2.10
Price / Sales3.80
Dividend Yield0.7%
DCF Value (model)$25.54
DCF Upside vs Price-30.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.09B
Net Margin20.3%
Return on Equity11.2%
Debt / Equity0.44
Current Ratio3.90
Revenue Growth (YoY)5.7%
EPS Growth (YoY)415.8%
FCF Growth (YoY)-10.5%
Financial Health — source: SEC EDGAR
Altman Z-Score3.40 (safe)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E18.9
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-10.0%
vs Industry9.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderWELLINGTON MANAGEMENT GROUP LLP ($575.11M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOThierry Bernard
Employees5,700
CountryNL
IPO Date1996-06-28

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Moderna, Inc. (MRNA)
  • Exelixis, Inc. (EXEL)
  • BioMarin Pharmaceutical Inc. (BMRN)
  • Radiopharm Theranostics Limited (RADX)
  • Elanco Animal Health Incorporated (ELAN)
  • Jazz Pharmaceuticals plc (JAZZ)
  • Axsome Therapeutics, Inc. (AXSM)
  • Halozyme Therapeutics, Inc. (HALO)
QGEN earnings history · QGEN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.